Article

The 32nd annual San Antonio Breast Cancer Symposium gets under way

Author(s):

On November 11, 1978, a group of 141 physicians and surgeons from a five state area got together during Breast Cancer Awareness Week to discuss ways to reduce the death rate caused by breast cancer in San Antonio and surrounding counties. Fast forward 31 years. This year's symposium will host an estimated 8,500 participants from more than 90 countries and instead of gathering for a single day, attendees will stay for five. What began as a novel idea has gained unfathomable momentum. The overall objective of SABCS, however, remains the same. Its mission is to produce a unique and comprehensive scientific meeting that encompasses the full spectrum of breast cancer research, facilitating the rapid translation of new knowledge into better care for breast cancer patients.For the next few days, the CURE team will be bringing you updates from this very important gathering of international thought leaders. Not only will we deliver the latest and greatest scientific news surrounding breast cancer, but will also be talking to survivors and advocates about their passionate causes. We'll be blogging, tweeting, writing, and filming daily so be sure to follow us here. Follow us on facebook and twitter too!

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
An expert highlights the impact of anemia in myelofibrosis and presented Ojjaara as a possible treatment to reduce transfusions and improve outcomes.
After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked her emotional recovery.
Terry Gillespie said the hardest parts of her cancer journey were the isolation, the impact of chemotherapy, and how unprepared she felt despite good guidance.
Dr. Erika Hamilton says social media and professional guidelines help patients stay informed about fast-changing breast cancer treatments and advances.
Outpatient CAR T-cell therapy has reduced hospital stays by two-thirds while maintaining safety for those with blood cancers, according to Dr. Olalekan Oluwole.
Related Content